Marciniak Andrzej, Jamroz-Wiśniewska Anna, Borkowska Ewelina, Bełtowski Jerzy
Department of Pathophysiology, Medical University, Lublin, Poland.
Acta Biochim Pol. 2005;52(4):803-9. Epub 2005 Aug 4.
Leptin, secreted by adipose tissue, is involved in the pathogenesis of arterial hypertension, however, the mechanisms through which leptin increases blood pressure are incompletely elucidated. We investigated the effect of leptin, administered for different time periods, on renal Na(+),K(+)-ATPase activity in the rat. Leptin was infused under anesthesia into the abdominal aorta proximally to the renal arteries for 0.5-3 h. Leptin administered at doses of 1 and 10 microg/min per kg for 30 min decreased the Na(+),K(+)-ATPase activity in the renal medulla. This effect disappeared when the hormone was infused for > or =1 h. Leptin infused for 3 h increased the Na(+),K(+)-ATPase activity in the renal cortex and medulla. The stimulatory effect was abolished by a specific inhibitor of Janus kinases (JAKs), tyrphostin AG490, as well as by an NAD(P)H oxidase inhibitor, apocynin. Leptin increased urinary excretion of hydrogen peroxide (H(2)O(2)) between 2 and 3 h of infusion. The effect of leptin on renal Na(+),K(+)-ATPase and urinary H(2)O(2) was augmented by a superoxide dismutase mimetic, tempol, and was abolished by catalase. In addition, infusion of H(2)O(2) for 30 min increased the Na(+),K(+)-ATPase activity. Inhibitors of extracellular signal regulated kinases (ERKs), PD98059 or U0126, prevented Na(+),K(+)-ATPase stimulation by leptin and H(2)O(2). These data indicate that leptin, by acting directly within the kidney, has a delayed stimulatory effect on Na(+),K(+)-ATPase, mediated by JAKs, H(2)O(2) and ERKs. This mechanism may contribute to the abnormal renal Na(+) handling in diseases associated with chronic hyperleptinemia such as diabetes and obesity.
瘦素由脂肪组织分泌,参与动脉高血压的发病机制,然而,瘦素升高血压的机制尚未完全阐明。我们研究了不同时间段给予瘦素对大鼠肾钠钾ATP酶活性的影响。在麻醉状态下,将瘦素注入肾动脉近端的腹主动脉,持续0.5 - 3小时。以每千克1和10微克/分钟的剂量给予瘦素30分钟,可降低肾髓质中的钠钾ATP酶活性。当激素输注时间≥1小时时,这种作用消失。输注3小时的瘦素可增加肾皮质和髓质中的钠钾ATP酶活性。Janus激酶(JAKs)的特异性抑制剂酪氨酸磷酸化抑制剂AG490以及NAD(P)H氧化酶抑制剂夹竹桃麻素可消除这种刺激作用。在输注2至3小时之间,瘦素增加了过氧化氢(H₂O₂)的尿排泄量。超氧化物歧化酶模拟物tempol增强了瘦素对肾钠钾ATP酶和尿H₂O₂的作用,而过氧化氢酶则消除了这种作用。此外,输注H₂O₂ 3分钟可增加钠钾ATP酶活性。细胞外信号调节激酶(ERK)抑制剂PD98059或U0126可阻止瘦素和H₂O₂对钠钾ATP酶的刺激。这些数据表明,瘦素通过直接作用于肾脏,对钠钾ATP酶具有延迟的刺激作用,该作用由JAKs、H₂O₂和ERK介导。这种机制可能导致与慢性高瘦素血症相关的疾病(如糖尿病和肥胖症)中肾脏对钠的异常处理。